Work

Abstract #LB-211: CYT997: Preclinical studies on the antivascular effects and mode of action of a phase II vascular disrupting agent.

Year: 2009

Type: conference-abstract

Source: Cancer Research

Authors: David J. Segal, Pradnya Gangatirkar, Max E. Joffe, Steven D. Shnyder, Cathy Malcontenti‐Wilson, Christopher Christophi, Andrew K. Powell, Gregg Smith, Christopher J. Burns, Emmanuelle Fantino

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2221199809

Cites:

Cited by:

Related to: 10